Though no timeline has been established for publication, FDA intends to issue several related pieces of guidance, including: – Final Guidance from CDRH on Marketing Submission Recommendations for a ...
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the recently published FDA ...
There seems to be a modern day gold rush as companies explore how to use machine learning in clinical decision support software. Unfortunately for libertarians, FDA will regulate some of that software ...